Sat, Jul 12, 2014, 6:47 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • williams4076 williams4076 Mar 8, 2013 12:32 PM Flag

    Vascepa and Lovaza differ chemically, new info:

    Under the new approval documents section "Chemistry Review" EPA - E is classified as a Type 1 chemical.
    A type 1 chemical is a NME. The reviewer was Martin Haber, Ph.D, the document is dated May 23, 2012. The addendum to CMC "The ONDQA Biopharmaceuticals review dated 30-MAY-2012 recommends approval. The Compliance/OMPQ/EES overall recommendation dated 25-JUL-2012 is ACCEPTABLE"

    Also on the ONDQA document pg 2/24 it states:
    "The drug substance Icosapent ethyl, an ethyl ester of the omega 3 fatty acid eicosapentaenoic (E-EPA). E-EPA is one of the two major components of the approved Lovaza, omega-3-acid ethyl esters, (Lovaza has a different applicant).

    Then it specifically describes Vascepa's capsule.

    In this approved document Vascepa is listed as Chemical Type 1 New Molecular entity.

    My DD, and this is new also:

    E-EPA is a synthetic derivate of the omega-3 fatty acid eicosapentaenoic acid (EPA).

    E-EPA IUPAC name: (Vascepa)
    Ethyl (5Z, 8Z, 11Z, 14Z, 17Z)-eicosa-5,8,11,14,17-pentaenoate
    CAS number 86227-47-6
    Molecular formula C22H34O2. Molar Mass 330.50

    Eicosapentaenoic Acid (Lovaza's EPA)
    (5Z, 8Z, 11Z, 14Z, 17Z)-5,8,11,14, 17 Icosapentaenoic acid
    CAS number 10417-94-4
    Molecular formula C20H30O2. Molar Mass 302.451

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.59-0.02(-1.24%)Jul 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.